Dubai, United Arab Emirates: Colliers, the global commercial real estate leader released its latest white paper on the IVF Market in the Middle East with a focus on the UAE, Saudi Arabia and Egypt.
The paper is the 14th edition in the “Puls Series” of research papres on healthcare in the MENA Region, it provids an in-debth analysis as to why in the MENA region despite an overall high population growth rate, IVF remains so popular.
“The current global IVF market is estimated to be between 10 billion to 13.7 billion USD. Whilst there is no definitive accurate data avilable for the Middle East, the estimated IVF market size drwan from number of cycles is roughly USD 200 million for the UAE, USD 300 million for KSA and USD 500 million for Egypt.” Says Mansoor Ahmed, Director | Health Care, Education , Development Solutions & PPP at Colliers – MENA Region.
The paper deep dives into MENA’s IVF market highlighting cost of IVF treatments and explaning why markerts such as Dubai, KSA and Egypt are considered “Hot Spots”. It also highlghts key insights for investors in the region as well as provides an outlook for the IVF market.
“IVF is not only sought after locally, but is one of the leading treatments undertaken by medical tourists in the UAE, especially in Dubai. On the other hand, KSA is also a growing market for IVF, with a plan to invest SR 250 billion in healthcare infrastructure and boost private sector participation from current 40% to 65% by 2030. ” Concludes Mansoor.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
